...to traditional tissue biopsies in cancer management, offering a minimally invasive method for analyzing circulating tumor
cells, cell-free DNA (cfDNA), and other biomarkers in bodily fluids (Ignatiadis et al. 2021; Zhu et al. 2023). Recent advancements in long-read sequencing
technologies have further enhanced...